Clinical Trial Update: Comparison of Platelet Inhibition With Adjunctive Cilostazol Versus High Maintenance-Dose Clopidogrel According to Hepatic Cytochrome 2C19 Allele (CYP2C19) Polymorphism [Phase 3]

View source ↗

Summary

This Phase 3 clinical trial update compares adjunctive cilostazol with high maintenance-dose clopidogrel for patients with coronary artery stenosis, in stratifi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Stenosis

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)
• Cilostazol (Cilostazol)

Snippet

Sponsor: Gyeongsang National University Hospital | Conditions: Coronary Artery Stenosis, Maximal Platelet Aggregation | Phase 3 | Status: UNKNOWN